Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11651
PUT
Dana Inc
DAN
$3.26B
| $59.1K | ﹤0.01% |
5,600
-11,600
| -67% | -$128K |
|
|
CLLS
11652
Cellectis
CLLS
$307M
| $59.1K | ﹤0.01% |
27,624
+925
| +3% | +$2.01K |
|
11653
Oric Pharmaceuticals
ORIC
$1.44B
| $59.1K | ﹤0.01% |
+5,767
| New | +$57K |
|
|
LILM
11654
PUT
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $59.1K | ﹤0.01% |
76,300
+39,200
| +106% | +$31.6K |
|
|
PARAA
11655
PUT
DELISTED
Paramount Global Class A
PARAA
| $59K | ﹤0.01% |
2,700
+100
| +4% | +$2.21K |
|
11656
PUT
BioAtla
BCAB
$5.15M
| $59K | ﹤0.01% |
670
+522
| +353% | +$43.8K |
|
11657
CALL
Stellus Capital Investment Corp
SCM
$250M
| $58.9K | ﹤0.01% |
4,300
-5,000
| -54% | -$69.3K |
|
|
VSTA
11658
DELISTED
Vasta Platform
VSTA
| $58.8K | ﹤0.01% |
22,354
+9,550
| +75% | +$26.6K |
|
|
DADA
11659
CALL
DELISTED
Dada Nexus
DADA
| $58.7K | ﹤0.01% |
30,900
+14,200
| +85% | +$18.6K |
|
11660
CALL
W&T Offshore
WTI
$554M
| $58.7K | ﹤0.01% |
27,300
+3,000
| +12% | +$6.67K |
|
11661
GEE Group
JOB
$27M
| $58.6K | ﹤0.01% |
224,882
+72,063
| +47% | +$20.3K |
|
|
GAN
11662
DELISTED
GAN Ltd
GAN
| $58.6K | ﹤0.01% |
+33,086
| New | +$54.5K |
|
11663
CALL
Certara
CERT
$1.22B
| $58.5K | ﹤0.01% |
5,000
-3,000
| -38% | -$39.6K |
|
11664
CALL
Telefônica Brasil
VIV
$18.2B
| $58.5K | ﹤0.01% |
+5,700
| New | +$52.7K |
|
11665
VOC Energy
VOC
$53.9M
| $58.5K | ﹤0.01% |
11,866
-22,995
| -66% | -$114K |
|
11666
PUT
AtaiBeckley Inc
ATAI
$2.69B
| $58.3K | ﹤0.01% |
50,300
-54,300
| -52% | -$72.4K |
|
11667
Medifast
MED
$128M
| $58.3K | ﹤0.01% |
3,046
-86,360
| -97% | -$1.66M |
|
11668
PUT
Mineralys Therapeutics
MLYS
$2.27B
| $58.1K | ﹤0.01% |
4,800
+3,200
| +200% | +$38.7K |
|
11669
Rani Therapeutics
RANI
$89.5M
| $58.1K | ﹤0.01% |
26,904
+12,139
| +82% | +$34.8K |
|
11670
CALL
AMERISAFE
AMSF
$513M
| $58K | ﹤0.01% |
1,200
-2,100
| -64% | -$99.9K |
|
|
JOYY
11671
CALL
JOYY Inc
JOYY
$3.68B
| $58K | ﹤0.01% |
1,600
-100
| -6% | -$3.44K |
|
|
UBX
11672
CALL
DELISTED
Unity Biotechnology
UBX
| $57.9K | ﹤0.01% |
39,400
+25,900
| +192% | +$38K |
|
11673
CALL
Duluth Holdings
DLTH
$153M
| $57.9K | ﹤0.01% |
15,400
+12,700
| +470% | +$46.4K |
|
11674
CALL
Ultralife
ULBI
$125M
| $57.9K | ﹤0.01% |
6,400
+3,600
| +129% | +$37.1K |
|
|
EVRI
11675
CALL
DELISTED
Everi Holdings
EVRI
| $57.8K | ﹤0.01% |
4,400
+4,000
| +1,000% | +$47.1K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.